Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2021 09:00 ET | Source: RP Management, LLC

Royalty Pharma to Present at Upcoming Investor Conferences

NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: Bank of...
April 21, 2021 16:15 ET | Source: RP Management, LLC

Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021

NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2021 financial results on Tuesday, May 11, 2021 before the U.S....
April 21, 2021 08:10 ET | Source: RP Management, LLC

Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes

NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced a collaboration with MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and...
April 15, 2021 09:00 ET | Source: RP Management, LLC

Royalty Pharma Declares Second-Quarter 2021 Dividend

NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2021 of $0.17 per class A...
April 08, 2021 07:40 ET | Source: RP Management, LLC

Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million

Dicerna to receive $180 million upfront and up to $60 million in potential additional milestone payments NEW YORK and LEXINGTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc...
April 01, 2021 07:30 ET | Source: RP Management, LLC

Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK

NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in the cabozantinib products Cabometyx and Cometriq from...
March 30, 2021 08:00 ET | Source: RP Management, LLC

Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director

NEW YORK, March 30, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Royalty Pharma plc (Nasdaq: RPRX) today announced that the independent directors of the Board have unanimously appointed Henry...
February 17, 2021 07:00 ET | Source: RP Management, LLC

Royalty Pharma Reports Q4 2020 and Full-Year Results

Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2)$2.4 billion of acquisitions announced in 2020; maintained leading share of biopharma royalty funding...
January 22, 2021 08:00 ET | Source: RP Management, LLC

Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021

NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its fourth quarter 2020 financial results on Wednesday, February 17, 2021 before the...
January 19, 2021 08:30 ET | Source: RP Management, LLC

Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences

NEW YORK and WALTHAM, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Minerva Neurosciences, Inc. (Nasdaq: NERV) today announced that Royalty Pharma will acquire...